# Task P2 — Owner POST Judgment (recorded after reading the synthesis)

experiment_type: product_interaction
record: owner-post-v1
recorded_at: 2026-08-08 (after reading owner-synthesis-v1.md)
status: FROZEN — recorded faithfully, not reinterpreted
owner: ThorStarlord (repository owner)

---

## Q1 — Is this recommendation useful?

**Yes — useful and decision-relevant.**

## Q2 — Did it change, narrow, sequence, or better justify what you would do?

**Yes — better justified my existing direction.** The direction (product /
interaction discovery first) remained broadly similar, but the justification
became materially stronger.

## Q3 — What specifically was decision-changing or decision-sharpening?

The owner identified two strongest candidates, plus one explicit non-claim:

1. **Reframing (decision-sharpening).** The interaction changed the
   engineering problem from "the validator is broken" to "producer/runtime
   contract is inconsistent with standalone validation". This materially
   changes what work the owner would authorize.
2. **Impact evidence (decision-sharpening).** The failure did not prevent P1
   from producing decision value, and downstream routing information
   (Section 13 machine fields) remained usable — this helps answer priority,
   not just diagnosis.
3. **CLI validate stub — a finding, not automatically decision-sharpening.**
   The owner would select this only if learning it actually affected what
   they would do.

## Owner's explicit pushback on the synthesis (recorded verbatim)

The synthesis said: "higher-value product work first — the owner-facing
synthesis step **and publishing 0.2.2**". The owner rejected the 0.2.2 part:

> "The publishing 0.2.2 part does not fit the product decision we had already
> reached. We explicitly concluded that PyPI was one optional installation
> experiment, not a product requirement, and stopped the release/credential
> thread. So P2 should not quietly turn: 'PyPI is an optional candidate' back
> into: 'publishing 0.2.2 is higher-value product work' unless P2 uncovered
> genuinely new evidence that justifies reopening that decision. From the
> summary you pasted, I don't see that justification."

## Owner's free-text POST answer (recorded verbatim)

> "Useful and decision-relevant overall. The main sharpening was that 'fix
> the validator' appears to be the wrong framing: the evidence points more
> toward a mode/producer-contract issue, and the observed impact does not
> justify making it the next major engineering task. That better justifies
> continuing higher-value product/interaction discovery first. I do not
> consider publishing 0.2.2 to be part of that conclusion; PyPI remains an
> optional distribution experiment, and P2 did not establish that
> publication should be reprioritized."

## Standing corrections to the P2 evidence package

- `owner-synthesis-v1.md` item (recommended sequence step 2) lists
  "publishing 0.2.2" as higher-value product work. Per this POST, that is an
  overreach: PyPI publication remains an optional distribution experiment per
  the owner's prior decision, and P2 produced no new evidence to reopen it.
  The synthesis's recommendation is therefore adopted by the owner **except**
  for that item; the owner-facing synthesis step remains the product work
  direction.
- `repo-sensemaker-investigation-v1.md` Section 10/11 carry the same 0.2.2
  framing; the owner's correction applies there as well. The brief's core
  diagnosis (Contract Mismatch on the standalone execution surface; the
  validator is not the defect) was not challenged.
